Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RNAZ

TransCode Therapeutics Inc

May 07 • 04:00PM ET

7.65

+0.13 1.73 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IMNN BCDA SHPH HOTH ARTL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-97.53	Insider Own	9.08%	Shs Outstand	0.92M	Perf Week	-4.49%
Market Cap	7.02M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.83M	Perf Month	-8.49%
Enterprise Value	130.75M	PEG	-	EPS next Q	-	Inst Own	4.96%	Short Float	4.95%	Perf Quarter	-23.27%
Income	-36.27M	P/S	-	EPS this Y	-	Inst Trans	3.85%	Short Ratio	3.13	Perf Half Y	-19.47%
Sales	0.00M	P/B	0.68	EPS next Y	-	ROA	-40.85%	Short Interest	0.04M	Perf YTD	12.01%
Book/sh	11.27	P/C	0.39	EPS next 5Y	-	ROE	-46.26%	52W High	20.99 -63.55%	Perf Year	-23.08%
Cash/sh	19.41	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-22.82%	52W Low	6.08 25.76%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.36% 6.74%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	93.85%	Oper. Margin	-	ATR (14)	0.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.29	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	34.28	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.29	EPS Q/Q	89.80%	SMA20	-8.86%	Beta	1.40	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-14.17%	Rel Volume	0.82	Prev Close	7.52
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-22.61%	Avg Volume	13.14K	Price	7.65
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	10,762	Change	1.73%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)